Home » Biogen Idec’s Fampyra Approved in Australia
Biogen Idec’s Fampyra Approved in Australia
Biogen Idec said Monday that Australian regulators approved marketing of its multiple sclerosis drug Fampyra.
Boston Globe
Boston Globe
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May